BG104654A - Method for treatment of chronic obstructive pulmonary disease (copd) - Google Patents

Method for treatment of chronic obstructive pulmonary disease (copd)

Info

Publication number
BG104654A
BG104654A BG104654A BG10465400A BG104654A BG 104654 A BG104654 A BG 104654A BG 104654 A BG104654 A BG 104654A BG 10465400 A BG10465400 A BG 10465400A BG 104654 A BG104654 A BG 104654A
Authority
BG
Bulgaria
Prior art keywords
copd
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
BG104654A
Other languages
Bulgarian (bg)
English (en)
Inventor
Siegfried Christensen
Theodore Torphy
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG104654A publication Critical patent/BG104654A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Indole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BG104654A 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd) BG104654A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7071898P 1998-01-07 1998-01-07
US10690898P 1998-10-28 1998-10-28
PCT/US1999/000214 WO1999034798A1 (fr) 1998-01-07 1999-01-06 Procede pour le traitement de la bronchopneumopathie chronique obstructive

Publications (1)

Publication Number Publication Date
BG104654A true BG104654A (en) 2001-04-30

Family

ID=26751429

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104654A BG104654A (en) 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd)

Country Status (34)

Country Link
US (1) US6369108B1 (fr)
EP (1) EP1051172B1 (fr)
JP (1) JP2003522095A (fr)
KR (1) KR100555824B1 (fr)
CN (1) CN1291891A (fr)
AP (1) AP2000001859A0 (fr)
AR (1) AR014411A1 (fr)
AT (1) ATE285234T1 (fr)
AU (1) AU752497B2 (fr)
BG (1) BG104654A (fr)
BR (1) BR9906803A (fr)
CA (1) CA2317720A1 (fr)
DE (1) DE69922786T2 (fr)
DZ (1) DZ2703A1 (fr)
EA (1) EA006382B1 (fr)
EG (1) EG23945A (fr)
ES (1) ES2234234T3 (fr)
HK (1) HK1033551A1 (fr)
HU (1) HUP0100888A3 (fr)
ID (1) ID26164A (fr)
IL (1) IL137104A0 (fr)
MA (1) MA26592A1 (fr)
MY (1) MY133014A (fr)
NO (1) NO20003481L (fr)
NZ (1) NZ505521A (fr)
OA (1) OA11443A (fr)
PE (1) PE20000231A1 (fr)
PL (1) PL341667A1 (fr)
PT (1) PT1051172E (fr)
SI (1) SI1051172T1 (fr)
SK (1) SK285149B6 (fr)
TR (1) TR200001819T2 (fr)
UY (1) UY25338A1 (fr)
WO (1) WO1999034798A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
AR024076A1 (es) * 1999-05-25 2002-09-04 Smithkline Beecham Corp Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato]
WO2001010385A2 (fr) * 1999-08-10 2001-02-15 Smithkline Beecham Corporation 4,4-diaryl cyclohexanes substitues en 1-4
JP2003534238A (ja) * 1999-12-15 2003-11-18 スミスクライン・ビーチャム・コーポレイション シス−４−シアノ−４−［３−（シクロペンチルオキシ）−４−メトキシフェニル］シクロヘキサン−１−カルボン酸の塩。
EP1265861A2 (fr) 2000-03-16 2002-12-18 Inflazyme Pharmaceuticals, Ltd. Inhibiteurs benzyles de pde4
DE10245153A1 (de) * 2002-09-27 2004-04-15 Infineon Technologies Ag Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren
JP2008542355A (ja) 2005-05-31 2008-11-27 ファイザー株式会社 Ｖｒ１アンタゴニストとしての置換アリールオキシ−ｎ−ビシクロメチルアセトアミド化合物
JP5384485B2 (ja) 2007-06-05 2014-01-08 サノフイ ジ（ヘテロ）アリールシクロヘキサン誘導体、それらの製造、それらの使用及びそれらを含む薬剤組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
JP3199380B2 (ja) * 1992-04-02 2001-08-20 スミスクライン・ビーチャム・コーポレイション 化合物
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas

Also Published As

Publication number Publication date
BR9906803A (pt) 2002-05-28
EA006382B1 (ru) 2005-12-29
IL137104A0 (en) 2001-06-14
OA11443A (en) 2004-04-28
DE69922786T2 (de) 2005-06-23
SK285149B6 (sk) 2006-07-07
SK10232000A3 (sk) 2001-01-18
MY133014A (en) 2007-10-31
SI1051172T1 (en) 2005-06-30
UY25338A1 (es) 2001-08-27
ATE285234T1 (de) 2005-01-15
CA2317720A1 (fr) 1999-07-15
EP1051172A2 (fr) 2000-11-15
CN1291891A (zh) 2001-04-18
ES2234234T3 (es) 2005-06-16
NO20003481L (no) 2000-08-25
HUP0100888A3 (en) 2003-07-28
EP1051172B1 (fr) 2004-12-22
PT1051172E (pt) 2005-03-31
PE20000231A1 (es) 2000-03-24
DZ2703A1 (fr) 2003-09-01
US6369108B1 (en) 2002-04-09
EP1051172A4 (fr) 2002-08-14
KR100555824B1 (ko) 2006-03-03
HUP0100888A2 (hu) 2001-08-28
AR014411A1 (es) 2001-02-28
AU2106099A (en) 1999-07-26
KR20010033909A (ko) 2001-04-25
NO20003481D0 (no) 2000-07-06
PL341667A1 (en) 2001-04-23
TR200001819T2 (tr) 2000-11-21
NZ505521A (en) 2004-02-27
WO1999034798A1 (fr) 1999-07-15
JP2003522095A (ja) 2003-07-22
MA26592A1 (fr) 2004-12-20
ID26164A (id) 2000-11-30
AU752497B2 (en) 2002-09-19
DE69922786D1 (de) 2005-01-27
AP2000001859A0 (en) 2000-09-30
HK1033551A1 (en) 2001-09-07
EG23945A (en) 2008-01-22
EA200000740A1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
NZ330216A (en) Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
HU9501569D0 (en) Oxalyl-amino-benzo-furane- and benzo-thienyl-derivatives, process for producing them and pharmaceutical compositions containing them
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
WO2001081312A3 (fr) Methode de traitement se basant sur l'utilisation de derives de phenyle et de biaryle comme inhibiteurs de prostaglandine e
MX9803809A (es) Inhibidores de hidroxamato de bifenilo de metaloproteinasas de matriz.
CA2180535A1 (fr) Procede de traitement du psoriasis par omeprazole ou autres composes apparentes
WO2003024391A3 (fr) Traitement et prevention de la mucosite chez les patients cancereux
CA2283399A1 (fr) Pyridazinones utilises comme inhibiteurs de cyclo-oxygenase-2
NO20000093D0 (no) (+)-Norcisaprid nyttig for 5-HT3 og 5-HT4-medierte forstyrrelser
ZA948027B (en) Methods for inhibiting angiogenesis and angiogenic diseases
BG104654A (en) Method for treatment of chronic obstructive pulmonary disease (copd)
IL126137A0 (en) New benzofuranone derivatives and a method for producing them
IL126235A0 (en) Compounds with growth hormone releasing properties
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
NZ502366A (en) Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
WO2003053352A3 (fr) Composes therapeutiques destines au traitement d'etats dyslipidemiques
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
EP0378146A3 (fr) Dérivés de polyamine comme agents antinéoplastiques
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
CA2301590A1 (fr) 2-aminopyridines utilisees comme inhibiteurs de la cyclo-oxygenase 2
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
HU9203052D0 (en) Method for treatment of hypertension
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders